1. Home
  2. NYT vs DVA Comparison

NYT vs DVA Comparison

Compare NYT & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYT
  • DVA
  • Stock Information
  • Founded
  • NYT 1851
  • DVA 1994
  • Country
  • NYT United States
  • DVA United States
  • Employees
  • NYT N/A
  • DVA N/A
  • Industry
  • NYT Newspapers/Magazines
  • DVA Misc Health and Biotechnology Services
  • Sector
  • NYT Consumer Discretionary
  • DVA Health Care
  • Exchange
  • NYT Nasdaq
  • DVA Nasdaq
  • Market Cap
  • NYT 9.3B
  • DVA 9.4B
  • IPO Year
  • NYT N/A
  • DVA 1995
  • Fundamental
  • Price
  • NYT $58.50
  • DVA $130.19
  • Analyst Decision
  • NYT Buy
  • DVA Hold
  • Analyst Count
  • NYT 6
  • DVA 3
  • Target Price
  • NYT $60.33
  • DVA $154.67
  • AVG Volume (30 Days)
  • NYT 1.3M
  • DVA 717.2K
  • Earning Date
  • NYT 11-03-2025
  • DVA 10-28-2025
  • Dividend Yield
  • NYT 1.24%
  • DVA N/A
  • EPS Growth
  • NYT 19.25
  • DVA 8.72
  • EPS
  • NYT 1.93
  • DVA 10.20
  • Revenue
  • NYT $2,661,490,000.00
  • DVA $13,161,328,000.00
  • Revenue This Year
  • NYT $9.93
  • DVA $5.96
  • Revenue Next Year
  • NYT $6.51
  • DVA $3.54
  • P/E Ratio
  • NYT $30.20
  • DVA $12.78
  • Revenue Growth
  • NYT 7.88
  • DVA 5.09
  • 52 Week Low
  • NYT $44.83
  • DVA $126.07
  • 52 Week High
  • NYT $62.24
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • NYT 50.72
  • DVA 40.98
  • Support Level
  • NYT $57.16
  • DVA $131.77
  • Resistance Level
  • NYT $59.05
  • DVA $131.34
  • Average True Range (ATR)
  • NYT 0.96
  • DVA 2.76
  • MACD
  • NYT -0.21
  • DVA -0.63
  • Stochastic Oscillator
  • NYT 47.08
  • DVA 28.39

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: